Itraderm Capsule contains Itraconazole 100mg, a broad-spectrum triazole antifungal agent effective against a variety of fungal infections. It works by inhibiting the synthesis of ergosterol, an essential component of fungal cell membranes, thereby disrupting membrane integrity and leading to fungal cell death. Itraderm is indicated for the treatment of dermatophytosis, onychomycosis, and other superficial and systemic fungal infections caused by susceptible strains. The capsule formulation ensures optimal bioavailability and convenient oral administration. Itraderm should be used under medical supervision, with dosage and duration tailored to the specific infection and patient condition. Common adverse effects may include gastrointestinal disturbances such as nausea, vomiting, and abdominal pain, as well as headache and rash. Caution is advised in patients with hepatic impairment, and liver function tests should be monitored periodically during therapy. Itraconazole has potential drug interactions due to its inhibition of cytochrome P450 enzymes; therefore, concurrent use with certain medications should be avoided or closely monitored. Itraderm is contraindicated in patients with known hypersensitivity to itraconazole or other azole antifungals. Pregnant and breastfeeding women should use this medication only if clearly needed and prescribed by a healthcare professional. Proper adherence to prescribed regimens enhances therapeutic outcomes and minimizes resistance development.